RACK1 and breast cancer: In addition, clinical outcomes from the GEO database (Affymetrix HGU133A and HGU133+2 microarrays) (44) indicated that RACK1 expression was not associated with RFS in breast cancer patients (Supplementary Figure 6B), while OS was significantly correlated with RACK1 expression (Supplementary Figure 6C).